Real-world outcomes of cladribine in people ≥55 years of age with multiple sclerosis. Smoot K, Stuchiner T, Gervasi-Follmar T, Chen C Mult Scler Relat Disord. 2026 Apr 27; 111:107215. PMID: 42096862. Abstract CommentRecommendBookmarkWatch
